Actively Recruiting

Phase 2
Age: 18Years +
All Genders
NCT06123715

Perioperative Vitamin C to Reduce Persistent Pain After Total Knee Arthroplasty

Led by University Health Network, Toronto · Updated on 2025-04-25

300

Participants Needed

3

Research Sites

141 weeks

Total Duration

On this page

Sponsors

U

University Health Network, Toronto

Lead Sponsor

C

Canadian Institutes of Health Research (CIHR)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Phase II Multicentre, pilot, parallel-group, blinded, 1:1 randomized controlled trial to determine the feasibility of conducting a larger definitive trail of using vitamin C to reduce persistent pain in patients undergoing total knee arthroplasty surgery.

CONDITIONS

Official Title

Perioperative Vitamin C to Reduce Persistent Pain After Total Knee Arthroplasty

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients over 18 years old
  • Undergoing unilateral or bilateral primary total knee arthroplasty for advanced osteoarthritis of the knee
Not Eligible

You will not qualify if you...

  • Total knee arthroplasty due to infection, fracture, ankylosing spondylitis, lupus, or psoriatic arthritis
  • History of kidney stones, acute or chronic renal failure, hemochromatosis, or glucose-6-phosphate deficiency
  • Unlikely to comply with follow-up (e.g., no fixed address, plans to move away)
  • Language difficulties preventing valid questionnaire completion
  • Planned staged bilateral total knee arthroplasty
  • Treating surgeon considers patient inappropriate for trial inclusion
  • Any allergy or sensitivity to milk
  • Pregnant or planning pregnancy during the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Sunnybrook - Holland Centre

Toronto, Ontario, Canada, M4Y 1H1

Actively Recruiting

2

Mount Sinai Hospital

Toronto, Ontario, Canada, M5G 1X5

Actively Recruiting

3

Toronto Western Hospital

Toronto, Ontario, Canada, M5T 2S8

Actively Recruiting

Loading map...

Research Team

J

James Khan, MD

CONTACT

N

Nour Ayach

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here